11/11/2024  20:42:16 Chg. +2.800 Volume Bid22:00:01 Ask22:00:01 Market Capitalization Dividend Y. P/E Ratio
220.000EUR +1.29% 646
Turnover: 141,198.200
219.600Bid Size: 36 220.900Ask Size: 36 63.64 bill.EUR - -

Business description

BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. The innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes.
 

Management board & Supervisory board

CEO
Tom Polen
Management board
Christopher DelOrefice, Ami Simunovich, Dave Hickey, David Shan, Elizabeth McCombs, Roland Goette, William R. Sigmund, II, Michelle Quinn, Shana Neal, Pavan Mocherla, Vishy Kanda, Michael Garrison, Denise Fleming, Tony Ezell, Richard Byrd, Herman Cueto, Jeff Silvestri
Supervisory board
Tom Polen, Bertram L. Scott, Timothy M. Ring, Marshall O. Larsen, Christopher Jones, Jeffrey W. Henderson, Claire M. Fraser, R. Andrew Eckert, Carrie Byington, Catherine M. Burzik, William M. Brown, Joanne Waldstreicher
 

Company data

Name: Becton, Dickinson and Company
Address: 1 Becton Drive,Franklin Lakes, New Jersey 07414, USA
Phone: +1-201-847-6800
Fax: -
E-mail: -
Internet: www.bd.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 30/09
Free Float: 77.40%
IPO date: 23/04/1962

Investor relations

Name: -
IR phone: +1-800-284-6845
IR Fax: -
IR e-mail: investor.relations@bd.com